Published Oct 31, 2018

Labshares Newton Launches Near Capacity and Announces Expansion Plans

Press Releases

Related or similar articles

August 19, 2019

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...
Member News
May 9, 2019

Labshares Newton Selects Savran Technologies as Winner of First Launch@Labshares Competition Valued at $50K

Second Launch@Shares Competition Announced in Collaboration with MTTC/MALSI Conference and MassBio’s MassCONNECT Program
Press Releases
January 21, 2025

Labshares and Thermo Fisher Scientific Announce Five-Year Renewal and Expansion of Partnership

Press Releases